Obstetrics & gynaecology

ADHD meds may help pregnant patients control opioid use disorder

Opioid overdoses for pregnant patients are at an all-time high in the United States, even as overall numbers are improving. Attention deficit hyperactivity disorder (ADHD) is highly correlated with substance use disorders, ...

Medications

FDA approves first liquid, nonstimulant ADHD treatment

The U.S. Food and Drug Administration has approved Tris Pharma's once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD).

Attention deficit disorders

Study promotes digital help for adults with ADHD

Digital health experts at Flinders University are developing a mobile self-monitoring app model to assist adults with Attention-Deficit Hyperactivity Disorder (ADHD) take a more pro-active role in their "wellness journey."

page 2 from 40